Glipizide 5 mg/1 (Glipizide TABLET) 5 mg/1

Glipizide 5 mg tablets are an oral medication used to manage blood sugar levels in adults with type 2 diabetes. This sulfonylurea helps the pancreas produce more insulin, aiding glucose control.

Strength

5 mg/1

Pack Size

500 TABLET in 1 BOTTLE, PLASTIC (0591-0460-05)

Manufacturer / TM Owner

Actavis Pharma, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glipizide is primarily used to treat type 2 diabetes by lowering blood sugar levels. It works by stimulating the pancreas to produce more insulin, which helps the body use glucose more effectively. This medication is often prescribed as part of a broader diabetes management plan, which may include diet and exercise.

Side Effects

Common effects of Glipizide may include low blood sugar, nausea, and dizziness. Some users may also experience weight gain or mild stomach discomfort. It's important to monitor blood sugar levels regularly while taking this medication.

Precautions & Warnings

Glipizide should be used with caution in individuals with liver or kidney problems. It is essential to follow the prescribed dosage and timing to avoid low blood sugar episodes. Always consult a healthcare provider before starting or stopping this medication.

Avoid Interactions

Glipizide may interact with other medications, including certain antibiotics, antifungal drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol can also affect blood sugar levels and should be consumed with caution. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Glipizide is used to manage blood sugar levels in adults with type 2 diabetes. It helps the pancreas produce more insulin, aiding in glucose control.

Glipizide is typically taken orally, usually before meals. The dosage and timing should be as prescribed by a healthcare provider.

Common side effects may include low blood sugar, nausea, dizziness, weight gain, and mild stomach discomfort.

Glipizide may interact with certain antibiotics, antifungal drugs, and NSAIDs. Always consult a healthcare provider before combining medications.

Precautions include monitoring blood sugar levels regularly, avoiding alcohol, and consulting a healthcare provider if you have liver or kidney problems.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.